Harlequin ichthyosis affects just a handful of newborns each year in the US, but the condition is unmistakable, marked by a ...

Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.

The genetic disease harlequin ichthyosis affects the transport of fats within the skin, resulting in hard, scalelike plaques ...

Scientists found that vitamin C doesn't just protect skin from damage - it actually turns on sleeping genes that help make ...

April 30, 2025 – The FDA has approved a new cell-based gene therapy for people with a rare genetic skin disorder known as recessive dystrophic epidermolysis bullosa (RDEB) after clinical studies ...

Tayma, 9, struggles with the most severe version of Epidermolysis Bullosa, a rare, agonizing disorder that causes skin to ...

April 29 (Reuters) - The U.S. Food and Drug Administration approved Abeona Therapeutics' (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn ...

FDA approval of Zevaskyn was based on findings from two clinical studies. In a single-center, open-label, phase 1/2a study involving 38 chronic wounds in seven patients, a single surgical ...

TUESDAY, April 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive ...